Arq, Inc. (ARQ) — Insider Trading

AI-Powered SEC Filing Analysis

← All ARQ filings

Want the newest filings?

This analysis covers the filing from 2026-03-25. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Insider Trading filings

Filed: 2026-03-25
  • Stacia Hansen, the Chief Accounting Officer of Arq, Inc. (ARQ), has disposed of 8,894 shares of the company's common stock through a share withholding transaction to cover tax obligations related to the vesting of restricted stock awards (RSAs).
  • This insider transaction represents a relatively small portion (around 12%) of Hansen's total beneficial ownership of 64,305 shares in the company.
  • The transaction appears to be a routine occurrence related to the vesting of equity awards and not indicative of a significant change in Hansen's ownership position or a strong signal about the company's prospects.
Filed: 2026-03-25
  • The filing indicates that Claiborne Benson Smith, the General Counsel and Corporate Secretary of Arq, Inc., has disposed of 8,025 shares of the company's common stock on March 23, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock awards.
  • The transaction represents a small fraction (about 8%) of Smith's total beneficial ownership of 94,466 shares of Arq, Inc. common stock, suggesting this may be a routine transaction rather than a significant change in his holdings.
  • Insider transactions can provide insights into management's views on the company's outlook and valuation, so this transaction is worth monitoring in the context of Arq, Inc.'s broader financial performance and any other insider trading activity.
Filed: 2026-03-25
  • The reporting person, Joseph M. Wong, is the Chief Technology Officer of Arq, Inc. and owns a significant number of shares (390,601) directly.
  • On March 23, 2026, the reporting person disposed of 10,085 shares of common stock, likely to satisfy tax withholding obligations related to the vesting of restricted stock awards.
  • The reporting of this transaction suggests ongoing insider activity and the potential for further changes in the reporting person's beneficial ownership of Arq, Inc. shares.
Filed: 2026-03-24
  • Richard Campbell-Breeden, a director of Arq, Inc., has acquired 150,000 shares of the company's common stock, indicating his confidence in the company's future prospects.
  • The purchase was made at a weighted average price of $2.2111 per share, suggesting Campbell-Breeden believes the stock is undervalued.
  • Omeshorn Holdings Limited, a company in which Campbell-Breeden is a director, also holds a substantial indirect beneficial ownership stake in Arq, further aligning his interests with the company's success.
Filed: 2026-03-19
  • Joseph M. Wong, the Chief Technology Officer of Arq, Inc., purchased 10,000 shares of the company's common stock on March 17, 2026 at a weighted average price of $1.89 per share.
  • This insider buying represents a direct ownership increase of 2.56% for Wong, who now beneficially owns 400,686 shares of Arq, Inc.
  • The timing and size of this insider purchase suggest Wong's confidence in the company's future prospects and may signal a positive outlook for investors.
Filed: 2026-03-16
  • Claiborne Benson Smith, the General Counsel and Corporate Secretary of Arq, Inc., has made two separate open market purchases of the company's common stock totaling 2,000 shares at an average price of around $1.92 per share.
  • This insider buying activity indicates that Smith has confidence in the company's prospects and aligns his personal interests with those of Arq's shareholders.
  • The timing of the transactions, with the second purchase occurring just a few days after the first, suggests a consistent and deliberate strategy to increase Smith's equity stake in the company.

Other reports for Arq, Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.